About Acusphere
Acusphere, Inc.™ is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary porous microsphere technology. We are focused on developing proprietary drugs that can offer significant benefits such as improved safety and efficacy, increased patient compliance, greater ease of use, expanded indications or reduced cost.
July 28, 2008
Acusphere Announces Staff Reductions+more
July 15, 2008
Acusphere Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rules+more
June 30, 2008
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
+more
May 20, 2008
Acusphere, Inc. Reschedules IP Payments+more
May 8, 2008
Acusphere, Inc. Reports Q1 2008 Financial Results and Business Highlights+more
March 31, 2008
Acusphere Licenses Hydrophobic Drug Delivery System to Cephalon for $10 Million+more
March 17, 2008
Acusphere, Inc. Reports Q4 2007 Financial Results and Business Highlights+more
January 3, 2008
Acusphere Issues Year-End Review to Shareholders+more
December 6, 2007
Acusphere Announces that Imagify(TM) Safety and ECHO Reader Training Data Will Be Presented at EuroEcho 2007+more
